248 related articles for article (PubMed ID: 33937284)
1. Endogenous Opioid Levels Do Not Correlate With Itch Intensity and Therapeutic Interventions in Hepatic Pruritus.
Düll MM; Wolf K; Vetter M; Dietrich P; Neurath MF; Kremer AE
Front Med (Lausanne); 2021; 8():641163. PubMed ID: 33937284
[No Abstract] [Full Text] [Related]
2. Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial.
de Vries E; Bolier R; Goet J; Parés A; Verbeek J; de Vree M; Drenth J; van Erpecum K; van Nieuwkerk K; van der Heide F; Mostafavi N; Helder J; Ponsioen C; Oude Elferink R; van Buuren H; Beuers U;
Gastroenterology; 2021 Feb; 160(3):734-743.e6. PubMed ID: 33031833
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and Management of Pruritus in PBC and PSC.
Kremer AE; Namer B; Bolier R; Fischer MJ; Oude Elferink RP; Beuers U
Dig Dis; 2015; 33 Suppl 2():164-75. PubMed ID: 26641452
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications.
Elmariah S; Chisolm S; Sciascia T; Kwatra SG
JAAD Int; 2022 Jun; 7():156-163. PubMed ID: 35497636
[TBL] [Abstract][Full Text] [Related]
5. Perspectives on Endogenous Opioids in Birds.
Scanes CG; Pierzchala-Koziec K
Front Physiol; 2018; 9():1842. PubMed ID: 30622479
[TBL] [Abstract][Full Text] [Related]
6. In major depression, increased kappa and mu opioid receptor levels are associated with immune activation.
Al-Hakeim HK; Zeki Al-Fadhel S; Al-Dujaili AH; Maes M
Acta Neuropsychiatr; 2020 Apr; 32(2):99-108. PubMed ID: 31753054
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Pruritus Secondary to Liver Disease.
Düll MM; Kremer AE
Curr Gastroenterol Rep; 2019 Jul; 21(9):48. PubMed ID: 31367993
[TBL] [Abstract][Full Text] [Related]
8. Endogenous Opioid Imbalance as a Potential Factor Involved in the Pathogenesis of Chronic Kidney Disease-Associated Pruritus in Dialysis Patients.
Wala-Zielińska K; Świerczyńska-Mróz K; Krajewski PK; Nowicka-Suszko D; Krajewska M; Szepietowski JC
J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048558
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.
Morgenweck J; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
Neuropharmacology; 2015 Dec; 99():600-9. PubMed ID: 26318102
[TBL] [Abstract][Full Text] [Related]
10. Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial.
Bolier R; de Vries ES; Parés A; Helder J; Kemper EM; Zwinderman K; Elferink RPO; Beuers U;
Trials; 2017 May; 18(1):230. PubMed ID: 28535810
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid is a potential mediator of cholestatic pruritus.
Kremer AE; Martens JJ; Kulik W; Ruëff F; Kuiper EM; van Buuren HR; van Erpecum KJ; Kondrackiene J; Prieto J; Rust C; Geenes VL; Williamson C; Moolenaar WH; Beuers U; Oude Elferink RP
Gastroenterology; 2010 Sep; 139(3):1008-18, 1018.e1. PubMed ID: 20546739
[TBL] [Abstract][Full Text] [Related]
12. Endogenous opiates and behavior: 2012.
Bodnar RJ
Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
[TBL] [Abstract][Full Text] [Related]
13. Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis.
Spivey JR; Jorgensen RA; Gores GJ; Lindor KD
Am J Gastroenterol; 1994 Nov; 89(11):2028-32. PubMed ID: 7942730
[TBL] [Abstract][Full Text] [Related]
14. IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH.
Xu J; Wang Y; Khoshdeli M; Peach M; Chuang JC; Lin J; Tsai WW; Mahadevan S; Minto W; Diehl L; Gupta R; Trauner M; Patel K; Noureddin M; Kowdley KV; Gulamhusein A; Bowlus CL; Huss RS; Myers RP; Chung C; Billin AN
Hepatology; 2023 Jan; 77(1):20-32. PubMed ID: 35686937
[TBL] [Abstract][Full Text] [Related]
15. Effects of butorphanol on morphine-induced itch and analgesia in primates.
Lee H; Naughton NN; Woods JH; Ko MC
Anesthesiology; 2007 Sep; 107(3):478-85. PubMed ID: 17721251
[TBL] [Abstract][Full Text] [Related]
16. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
[TBL] [Abstract][Full Text] [Related]
17. Use of Butorphanol as Treatment for Cholestatic Itch.
Golpanian RS; Yosipovitch G; Levy C
Dig Dis Sci; 2021 May; 66(5):1693-1699. PubMed ID: 32556969
[TBL] [Abstract][Full Text] [Related]
18. Brain and plasma levels of opioid peptides are altered in rats with thioacetamide-induced fulminant hepatic failure: implications for the treatment of hepatic encephalopathy with opioid antagonists.
Yurdaydin C; Li Y; Ha JH; Jones EA; Rothman R; Basile AS
J Pharmacol Exp Ther; 1995 Apr; 273(1):185-92. PubMed ID: 7714765
[TBL] [Abstract][Full Text] [Related]
19. Role of kappa-opioid and mu-opioid receptors in pruritus: Peripheral and central itch circuits.
Kim BS; Inan S; Ständer S; Sciascia T; Szepietowski JC; Yosipovitch G
Exp Dermatol; 2022 Dec; 31(12):1900-1907. PubMed ID: 36054458
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of pruritus in cholestasis: understanding and treating the itch.
Beuers U; Wolters F; Oude Elferink RPJ
Nat Rev Gastroenterol Hepatol; 2023 Jan; 20(1):26-36. PubMed ID: 36307649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
